Skip to main content
. 2012 Jan 16;35(2):226–232. doi: 10.2337/dc11-1443

Table 2.

Effect of 1-year combined intervention with flavan-3-ols and isoflavones on biomarkers of CVD risk in medicated postmenopausal patients with type 2 diabetes

graphic file with name 226tbl2.jpg